ADRA2B polymorphism as a putative biomarker for the acquisition of anxiety based on inadequate storage of emotional memories

ADRA2B polymorphism as a putative biomarker for the acquisition of anxiety based on inadequate storage of emotional memories - Is there a genetic risk for developing anxiety?

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35676

Enrollment

120

Registered

2008-07-10

Start date

2008-09-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Score on Dental Anxiety Scale (DAS) >15

Exclusion criteria

Exclusion criteria: people with psychobiological disorders, behavioral disorders, an age below 18 or above 65 or people with a cognitive impairment.

Design outcomes

Primary

Measure	Time frame
This is a one-time intervention evaluating the proportions of individuals with the ADRA2B polymorphism between both groups as well as differences in (sub) scores on the DAS, VAG and IES questionnaires	—

Countries

Netherlands

Outcome results